Brian Goff, Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 19,068 shares at $34.71 ($662K) on 2026-04-02, disclosed to the SEC on 2026-04-06.
Scheduled sale ($662k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.71 | 6,596 | $229K | 34.6% |
| 2 | $34.71 | 12,472 | $433K | 65.4% |
| Total | $34.71 avg | 19,068 | $662K | 100% |
| Filing → |
| AGIO | SELL | 2025-08-12 | $813K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $1.3M | — | Filing → |
| AGIO | SELL | 2025-03-04 | $920K | — | Filing → |